Company Profile

Abram Scientific Inc
Profile last edited on: 3/24/21      CAGE: 72CS8      UEI: J12WGSNJJMR5

Business Identifier: Fast hemostasis information for improved outcomes
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

100 Devon Avenue Unit 15
Pleasant Hill, CA 94523
   (925) 998-3299
Location: Single
Congr. District: 11
County: Contra Costa

Public Profile

A medical diagnostic device company with a vision to develop a low cost diagnostic platform for hemostasis monitoring in cardiovascular disease management, Abram Scientific, Inc has developed a first-of-its-kind, disruptive blood coagulation diagnostic platform capable of translating multiple lab-based tests to a cost-effective, hand-held format. With the firm's initial work in the SBIR arena being NSF funded, in January 2021 it was announced that the Army had awarded to firm a medical research grant for the firm to deliver a portable viscoelastic, blood coagulation diagnostic platform for COVID-19 associated Coagulopathy Management. The firm's CoagCare System is a novel diagnostic platform for diagnosis and characterization of coagulation-related disorders, delivering rapid hemostasis information to improve clinical outcomes.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Edward Brennan -- CEO

  Abhishek Ramkumar -- President and Founder

  Norimasa Yoshimizu -- President; Chief Financial Officer

Company News

There are no news available.